Eva Yin, Partner at Wilson Sonsini

Today, my guest is Eva Yin, Ph.D., M.P.H., a Partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine.

Eva also reviews contracts and compliance policies for manufacturers; and provides legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations. Eva holds a J.D. from University of California College of the Law, San Francisco, an M.P.H. from Johns Hopkins Bloomberg School of Public Health, a Ph.D. in Molecular Biophysics and Biochemistry from Yale University and a B.S. in Chemistry and Biology from Emory University.